ShockWave Medical, Inc.

ShockWave Medical, Inc. develops and commercializes intravascular lithotripsy technology for treating calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases globally. The company's product line includes M5 catheters for above-the-knee peripheral artery disease (PAD), C2 catheters for coronary artery disease, and S4 catheters for below-the-knee PAD. It generates revenue by selling these catheters to interventional cardiologists, vascular surgeons, and interventional radiologists through its sales representatives, sales managers, and distributors.

Products

• M5 catheters for above-the-knee peripheral artery disease (PAD)

• C2 catheters for coronary artery disease

• S4 catheters for below-the-knee PAD